Albert P. Garcia-Romeu, Ph.D.
Affiliations: | Johns Hopkins University, Baltimore, MD |
Google:
"Albert Garcia-Romeu"Parents
Sign in to add mentor| Matthew Johnson | post-doc | Johns Hopkins | |
| Roland Griffiths | post-doc | 2012-2016 | Johns Hopkins (Neurotree) |
| Roland Griffiths | post-doc | 2012-2016 | Johns Hopkins (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Devenot N, Seale-Feldman A, Smith E, et al. (2024) Psychedelic Identity Shift: A Critical Approach to Set And Setting. Kennedy Institute of Ethics Journal. 32: 359-399 |
| Mathai DS, Hilbert S, Sepeda ND, et al. (2023) Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers. Psychedelic Medicine (New Rochelle, N.Y.). 1: 241-252 |
| Yaden DB, Berghella AP, Hendricks PS, et al. (2023) IUPHAR-review: The Integration of Classic Psychedelics into Current Substance Use Disorder Treatment Models. Pharmacological Research. 106998 |
| Nayak SM, Jackson H, Sepeda ND, et al. (2023) Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. Frontiers in Psychiatry. 14: 1199642 |
| Henningfield JE, Chawarski MC, Garcia-Romeu A, et al. (2023) Kratom withdrawal: Discussions and conclusions of a scientific expert forum. Drug and Alcohol Dependence Reports. 7: 100142 |
| Smith KE, Dunn KE, Epstein DH, et al. (2022) Need for clarity and context in case reports on kratom use, assessment, and intervention. Substance Abuse. 43: 1221-1224 |
| Swogger MT, Smith KE, Garcia-Romeu A, et al. (2022) Understanding Kratom Use: A Guide for Healthcare Providers. Frontiers in Pharmacology. 13: 801855 |
| Henningfield JE, Grundmann O, Garcia-Romeu A, et al. (2022) We Need Better Estimates of Kratom Use Prevalence. American Journal of Preventive Medicine. 62: 132-133 |
| Bobe JR, Jutras BL, Horn EJ, et al. (2021) Recent Progress in Lyme Disease and Remaining Challenges. Frontiers in Medicine. 8: 666554 |
| Yaden DB, Berghella AP, Regier PS, et al. (2021) Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs. The International Journal On Drug Policy. 98: 103380 |